| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $20.05B | +14.6% |
| Cost of Revenue | $16.61B | +11.8% |
| Gross Profit | $922.0M | — |
| R&D Expense | $1.29B | +15.1% |
| SG&A Expense | $1.44B | +26.2% |
| Operating Income | $1.56B | +23.4% |
| Interest Expense | $285.0M | +30.1% |
| Pre-tax Income | $1.34B | +35.1% |
| Income Tax | -$1.93B |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.64B | +7.1% |
| Accounts Receivable | $3.55B | +3.3% |
| Inventory | $2.37B | +1.1% |
| Current Assets | $8.25B | +5.9% |
| Total Assets | $24.43B | +11.6% |
| Current Liabilities | $4.81B | -1.2% |
| Long-term Debt | $6.30B | -4.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.90B | +50.1% |
| Investing Cash Flow | -$1.00B | +80.7% |
| Financing Cash Flow | -$807.0M | -134.2% |
| -1693.4% |
| Net Income | $2.94B | +394.6% |
| EPS (Basic) | $10.50 | +435.7% |
| EPS (Diluted) | $10.39 | +430.1% |
| Total Liabilities |
| $12.58B |
| -1.6% |
| Stockholders' Equity | $11.55B | +31.1% |